Understanding Multisystem Inflammatory Syndrome in Children
Dongngan Truong, MD, and Jane Newburger, MD, discuss the current clinical understanding of MIS-C.
National Wear Red Day: Perspectives on Women's Cardiovascular Health
Two experts offer perspectives on the importance and state of cardiovascular health in women.
How DBV Intends to Assess its Peanut Immunotherapy Patch Long-term
Pending FDA decision, the Viaskin Peanut patch would be considered for lengthier benefit studies.
Multidisciplinary Management of Atopic Dermatitis
What Goes Into Asthma Management Guidelines
Anne Dixon, MD, explains how it took 6 years to update recommendations for new asthma therapies.
Advice on Collaborative Care for Atopic Dermatitis
Approaching Management of Atopic Dermatitis
Impact of Atopic Dermatitis on Patients and Caregivers
An Overview of Atopic Dermatitis
Pharis Mohideen, MD, MS: Updates on the Viaskin Peanut Patch
The epicutaneous immunotherapy for peanut allergy is continuing discussions with the FDA. What is its potential in allergic care?
Rakesh Jetly, MD: The Balance of PTSD Treatment
New study will look at psychedelics as a treatment for PTSD.
National Blood Donor Month: Advice to Clinicians
Rodney Wilson, spokesperson from the American Red Cross, offers some final thoughts on how providers can encourage blood donations among their patients.
National Blood Donor Month: Meeting Unprecendented Challenges
A spokesperson from American Red Cross discusses the importance of National Blood Donor Month and the challenges faced during the COVID-19 pandemic.
The Importance of an ADHD-Research Conference: Matthew Brams, MD
Dr. Matthew Brams presented new data showing the efficacy of CTx-1301 for ADHD.
Matthew Brams, MD: A Multidose ADHD Pill
CTx-1301's formulation enables 3 different doses within 1 pill for ADHD.
Matthew Brams, MD: Positive Results for CTx-1301 for Adults with ADHD
Researchers are prepared a phase 3 trial testing the treatment in adults with ADHD.
ADHD Coaching During COVID-19
The role of many in psychiatry has changed during the COVID-19 pandemic.
Better Interprofessional Communication Needed in ADHD Coaching
A pair of researchers present plans to improve collaboration with other professionals in ADHD.
David W. Goodman, MD: Silver Linings in ADHD
Dr. David Goodman predicts some patients may improve their organizational skills during the pandemic.
David W. Goodman, MD: Adult ADHD Challenges During COVID-19
Adults with ADHD may face a number of challenges during the ongoing pandemic.
David W. Goodman, MD: APSARD 2021 Bringing Together International ADHD Research
The virtual conference will feature researchers from the US, Germany, Japan, and more.
What Links Asthma to Obesity?
A conversation on how associations between the chronic conditions have become better understood in 10 years.
Peter Lio, MD: Managing and Treating Itch
Peter Lio, MD, discusses conventional therapeutic options for pruritus.
ADM Brett Giroir, MD: Mobilizing a Response to Sickle Cell
ADM Giroir, MD, discusses additional examples of efforts to optimize sickle cell care.
ADM Brett Giroir, MD: The Momentum of Sickle Cell Care
The US Assistant Secretary for Health provides a top-down, government-level perspective on how sickle cell care has advanced in recent years.
Peter Lio, MD: Classifying Itch
Peter Lio, MD, discusses the various underlying causes behind itch.
A. Sidney Barritt, MD: Updating TARGET-NASH
The TARGET-NASH study seeks to shed light on treatment for NASH and NAFLD.
Stefan Bornstein, MD: Adherence Concerns for Diabetic Patients
Amputations have increased 30% among diabetic patients since the pandemic began.
Kausik Ray, MD: Treating Diabetes During COVID-19
There is concern over whether or not patients are adhering to their treatment during the pandemic.
Francesco Giorgino, MD, PhD: Optimizing Diabetes Treatment with SGLT2 Inhibitors
Dr. Giorgino discusses how combining SGLT2 Inhibitors and GLP-1RA could be combined for treating type 2 diabetes.